Category: ocm

By Global Pharma Tech Summit 2025 September 4, 2024 ocm

Dr. Julia Appelskog

Dr. Julia Appelskog EU/UK QPPV and heads the QPPV Office at Novavax Dr. Julia Appelskog is a leading pharmacovigilance (PV) expert with over 22 years of experience in drug safety, clinical operations, and quality assurance. She serves as the EU/UK QPPV and heads the QPPV Office at Novavax.

By Global Pharma Tech Summit 2025 September 4, 2024 ocm

Dr. Tina Barton

Dr. Tina Barton Chief Operating Officer, eMQT Dr. Tina Barton is a drug development specialist with over 40 years’ experience, working in partnership to lead for success as a customer-focused senior leader. She holds a BSc, PhD and MBA alongside over 50 academic publications and is an Honorary

1
2